Term
|
Definition
5-HETE
lipoxygenase pathway product
inhibit platelet aggregation
serve as chemotactic factor to attract leukocyte to site of injury |
|
|
Term
|
Definition
5-HPETE
lipoxygenase pathway product
no physiological function |
|
|
Term
|
Definition
Acarbose
alpha-glucosidase inhibitor
fungal metabolite derived from actinomyces |
|
|
Term
|
Definition
Acetaminophen
p-aminophenol
useful for pain and fever NOT inflammation
do not inhibit COX
overdose can lead to hepatic necrosis |
|
|
Term
|
Definition
Acetanilide
p-aminophenol
useful for pain and fever NOT inflammation
do not inhibit COX
overdose can lead to hepatic necrosis |
|
|
Term
|
Definition
Acetohexamide
1st Gen Sulfonylurea
|
|
|
Term
|
Definition
Alprostadil
PGE1 analog
Maintain patency of ductus arteriosis after birth
Erectile dysfunction |
|
|
Term
|
Definition
Amylin
37 amino acid peptide hormone secreted by pancreatic beta cells at same time as insulin
Contributes to glycemic control
Slow gastric emptying
Inhibition of digestive secretion
Inhibiting secretion of glucagon |
|
|
Term
|
Definition
Anthranilic Acid
NSAID
Reversible competitive inhibitor of COX
Analog of salicylic acid |
|
|
Term
|
Definition
Arachidonic Acid
Fatty Acid Precursor to Eicosanoids
Released from cell membrane via PLA2 |
|
|
Term
|
Definition
Insulin Aspart
Rapid Acting Insulin
Eliminates ability to dimerize/hexamerize and results in faster absorption rate |
|
|
Term
|
Definition
Aspirin
Type 2 salicylate ester
Analgesic, antipyretic, anti-inflammatory
Irreversible COX inhibitor. After acetylation of COX, salicylic acid acts as a reversible inhibitor. |
|
|
Term
|
Definition
Aspirin Salt
NSAID
Type 2 salicylic acid ester
Irreversible COX inhibitor |
|
|
Term
|
Definition
Bimatoprost
Synthetic PGF agent
Used as eye drops for ocular hypertension and glaucoma |
|
|
Term
|
Definition
Canagiflozen
SGLT-2 Inhibitor
|
|
|
Term
|
Definition
Carboprost
PGF analog
Used in combination with mifepristone as abortifacient
Used to stimulate uterine contractions |
|
|
Term
|
Definition
Carprofen
NSAID
Propionic Acid veterinary analgesic
both rings are COPLANAR--does not bind site 3 |
|
|
Term
|
Definition
Celecoxib
NSAID
COX 2 inhibitor
Inhibit production of PGI2, may increase risk of vascular disease |
|
|
Term
|
Definition
Chlorpropamide
Sulfonylurea
Extremely long half life/duration of action
Potentially prolong hypoglycemia
Potentially potentiate ADH sensitivity (H2O retention) |
|
|
Term
|
Definition
Choline Salicylate
NSAID
Type 1 salicylic acid ester
|
|
|
Term
|
Definition
Dapagliflozin
SGLT-2 Inhibitor |
|
|
Term
|
Definition
Detemir Insulin
Long acting insulin
Forms hexamer, slowly resleasing
Monomer is more lipophilic--bound to albumin in circulation |
|
|
Term
|
Definition
Diclofenac
NSAID
Anthranilic Acid Analog
Inhibits COX and lipoxygenase
Inhibits release and reuptake of arachidonic acid
optimal spacing of atoms between site 1 & 2 increases potency
|
|
|
Term
|
Definition
Dinoprostone
PGE2 analog
Used in combination with mifepristone as abortifacient
Stimulates uterine contraction
Used as a vaginal suppository for induction of labor |
|
|
Term
|
Definition
Empagliflozin
SGLT-2 Inhibitor |
|
|
Term
|
Definition
Fenoprofen
NSAID
Propionic Acid Derivative
Inhibits COX & lipoxygenase
|
|
|
Term
|
Definition
Flubiprofen
NSAID
Propionic Acid Derivative
Opthalmic and oral systemic use |
|
|
Term
|
Definition
Glargine Insulin
Long acting insulin
Isoelectric point neutral at physiological pH
Microcrystal precipitate forms--slowly releases insulin |
|
|
Term
|
Definition
Glimepiride
3rd Generation Sulfonylurea
Stimulate insulin secretion
Stimulate translocation of GLUT4 from cytoplasm to cell membrane |
|
|
Term
|
Definition
Glipizide
2nd Gen Sulfonylurea
|
|
|
Term
|
Definition
Glulisine Insulin
Rapid Acting Insulin
Eliminates ability to dimerize/hexamerize
|
|
|
Term
|
Definition
Glyburide
2nd Gen Sulfonylurea |
|
|
Term
|
Definition
Human GLP-1
Incretin
Secreted by L cells located in small intestine
Closes ATP-linked K+ channel
Inhibits glucagon secretion & hepatic glucose secretion
Stimulates insulin secretion
Slows gastric emptying
Promotes satiety
Restores beta cell function
Promotes beta cell differentiation |
|
|
Term
|
Definition
Regular Human Insulin
Onset 30 min-1 hr, duration 6-8 hr
|
|
|
Term
|
Definition
Ibuprofen
NSAID
Propionic Acid Derivative
Lacks 2nd aromatic ring ut possesss sec-butyl substituent that presumably renders drug slightly less potent |
|
|
Term
|
Definition
Iloprost
PGI2 analog
Lowers peripheral, pulmonary, and coronary resistance
Used for primary pulmonary hypertension
|
|
|
Term
|
Definition
Inactive PGE2
ketone group eliminates activity |
|
|
Term
|
Definition
Indomethacin
NSAID
Indolacetic Acid Derivative
More potent than aspirin as anti-inflammatory and anti-pyretic agent
One of the most potent inhibitors of COX
Side effects: GI and CNS (severe frontal headache) |
|
|
Term
|
Definition
Ketoprofen
NSAID
Propionic Acid Derivative
Inhibitis COX and lipoxygenase |
|
|
Term
|
Definition
Ketorolac tromethamine
NSAID Pyrrolacetic Acid Derivative
As active as indomethacin--very potent COX inhibitor
|
|
|
Term
|
Definition
Latanoprost
Synthetic PGF derivative
Eye drop for ocular hypertension and glaucoma |
|
|
Term
|
Definition
Linagliptin
DPP4 Inhibitor
Side effects: Nasopharyngitis, hypoglycemia, pancreatitis |
|
|
Term
|
Definition
Liraglutide
97% homology to human GLP-1
long acting
slow absorption from subcutis |
|
|
Term
|
Definition
Lispro Insulin
Rapid Acting Insulin
Eliminates ability to dimerize |
|
|
Term
|
Definition
LTA4
Leukotriene (Lipoxygenase Pathway)
No physiological function |
|
|
Term
|
Definition
LTB4
Leukotriene (Lipoxygenase Pathway)
Increase leukocyte chemotaxis |
|
|
Term
|
Definition
Magnesium salicylate
NSAID
Type 1 salicylate ester
Useful for patients with restricted sodium diet |
|
|
Term
|
Definition
Meclofenamate
Anthranilic Acid Analog
disubstitution makes 10x more potent |
|
|
Term
|
Definition
Mefenamic Acid
Anthranilic Acid Derivative
|
|
|
Term
|
Definition
Meloxicam
NSAID Oxicam
More selective as COX 2 inhibitor
|
|
|
Term
|
Definition
Metformin
Biguanide
Rarely causes hypoglycemia
Can cause weight loss and decrease insulin resistance in obese patients
Reported to have beneficial effects on serum lipids
Side effects: Metallic taste, epigastric distress, lactic acidosis |
|
|
Term
|
Definition
Methyl Salicylate
NSAID
Type 1 salicylate ester
Prodrug |
|
|
Term
|
Definition
Miglitol
Alpha-glucosidase inhibitor
|
|
|
Term
|
Definition
Misoprostol
Stable analog of PGE1
Used as GI protectant on long term NSAID usage
Orally active prodrug
Drug of choice for use with mifepristone as abortifacient
|
|
|
Term
|
Definition
Montelukast
Leukotriene Receptor Antagonist
Prophylatic and chronic use for asthma |
|
|
Term
|
Definition
N-arylanthranilic Acid
NSAID
Anthranilic Acid Analog
SAR: Monosub at 2 or disub at 2,6 to enhance activity
|
|
|
Term
|
Definition
Naproxen
NSAID
Propionic Acid Derivative
Does not possess 2nd non-coplanar ring
Only drug marketed in optically pure form |
|
|
Term
|
Definition
Nateglinide
Phenylalanine Analog of sulfonylurea
Stimulates insulin secretion |
|
|
Term
|
Definition
Oxaprozin
NSAID Propionic Acid Derivative (aryl propionic acid)
Less potent because 3 carbons between site 1 and 2 |
|
|
Term
|
Definition
PGD2
weak inhibitor of platelet aggregation
mediates inflammation by causing vasodilation and increasing vascular permeability |
|
|
Term
|
Definition
PGE1
mediates inflammation by causing vasodilaiton |
|
|
Term
|
Definition
PGE2
Increases thermoregulatory set point
GI Protective effect
Stimulates hyperalgesia (increase sensitivity to pain)
Uterine contraction
Mediates inflammation by causing vasodilation and increasing vascular permeability
Inhibits reabsorption of sodium and water in collecting duct |
|
|
Term
|
Definition
|
|
Term
|
Definition
PGF2a
Stimulate uterine muscle contraction
Increase thermoregulatory set point |
|
|
Term
|
Definition
PGG2
No specific physiological function |
|
|
Term
|
Definition
PGH2
No specific physiological function |
|
|
Term
|
Definition
PGI2
ProstaCYLCIN
Inhibit platelet aggregation
Potent vasodilator of smooth muscle
Mediate inflammation by causing vasodilation and increasing vascular permeabilty
|
|
|
Term
|
Definition
Phenacetin
p-aminophenol
Useful for pain and fever but NOT inflammation
Does not inhibit COX |
|
|
Term
|
Definition
Phenformin
Biguanides
Removed from market due to fatal lactic acidosis
Rarely causes hypoglycemia
Can cause weight loss and decrease insulin resistance in obese patients
Reported to have beneficial effects on serum lipids
Side effects: Metallic taste, epigastric distress, lactic acidosis |
|
|
Term
|
Definition
Pioglitazone
Thiazolidinedione
Insulin Sensitizers
Increased risk of fracture in female patients |
|
|
Term
|
Definition
Pramlintide
Synthetic amylin analog
Use in conjunction with insulin before meal |
|
|
Term
|
Definition
|
|
Term
|
Definition
Repaglinide
Stimulates insulin secretion
Related to sulfonylureas, but NOT in this class |
|
|
Term
|
Definition
Rofecoxib
NSAID
COX-2 inhibitor
Discontinued due to CV side effects
|
|
|
Term
|
Definition
Rosiglitazone
Thiazolidinedione
Insulin sensitizer
Safety alert: increased risk of heart attack |
|
|
Term
|
Definition
Salicylamide
NSAID
Salicylate analog
Weak analgesic and antipyretic
NOT anti-inflammatory
Does not cause GI ulceration, absorbed only in intestine
Does NOT inhibit COX |
|
|
Term
|
Definition
Salsalate NSAID NOT irreversible, but competitive inhibitor
Less GI irritation
Transported to SI and metabolized to 2 salicylic acids |
|
|
Term
|
Definition
Saxagliptin
DPP4 Inhibitor
Adverse effect: lymphocytopenia
|
|
|
Term
|
Definition
Sitagliptin
DPP4 Inhibitor
|
|
|
Term
|
Definition
Sodium salicylate
NSAID Type 1 salicylic acid ester
|
|
|
Term
|
Definition
Sodium thiosalicylate
NSAID
weak analgesic and anti-pyretic, also anti-inflammatory
|
|
|
Term
|
Definition
Sulindac
NSAID
Indolacetic acid derivative
Prodrug
Only Z isomer active
Fever GI disturbances because absorbed as inactive sulfoxide |
|
|
Term
|
Definition
Suprofen
NSAID Propionic acid derivative
Withdrawn due to renal toxicity
Reintroduced for opthalmic use |
|
|
Term
|
Definition
Tolazamide
1st Gen Sulfonylurea
Slow absorption, slow onset |
|
|
Term
|
Definition
Tolbutamide
1st Gen Sulfonylurea
Rapid onset, shortest DOA
Diagnostic tool for pancreatic function |
|
|
Term
|
Definition
Tolmetin
NSAID
Pyrrolacetic Acid Derivative
|
|
|
Term
|
Definition
Travoprost
Synthetic PGF analog
Available as eye drop for ocular hypertension and glaucoma |
|
|
Term
|
Definition
Treprostinil Sodium
PGI2 analog
Lowers peripheral, pulmonary, and coronary resistance
Used for primary pulmonary hypertension |
|
|
Term
|
Definition
TXA2
Induce platelet aggregation, produced by plateletswhen there is tissue injury
Causes vasoconstriction |
|
|
Term
|
Definition
type 1 salicylic acid ester |
|
|
Term
|
Definition
type 2 salicylic acid ester |
|
|
Term
|
Definition
Unoprostone isopropyl
Synthetic PGF analog
Available as eye drop for ocular hypertension and glaucoma |
|
|
Term
|
Definition
Valdecoxib
NSAID
COX-2 inhibitor
Discontinued due to severe skin reaction |
|
|
Term
|
Definition
Zafirlukast
Leukotriene receptor antagonist
Prophylactic and chronic use to treat asthma |
|
|
Term
|
Definition
Zileuton
5-lipoxygenase inhibitor
Indicated for prophylaxis and chronic treatment of asthma
Contraindicated in patients with active liver disease or persistant hepatic function enzyme elevation |
|
|
Term
|
Definition
Zomepirac
NSAID
Pyrrolacetic Acid derivative
Removed from market for anaphylactic reaction |
|
|